El SharkwyIAAbd El AzizWM
When administered, Semaglutide binds to GLP-1 receptors, stimulating the pancreas to enhance insulin secretion in response to meals, while simultaneously reducing glucagon release, helping to prevent excessive blood sugar levels
The mechanism of GLP-1 agonists involves slowing gastric emptying, which prolongs the feeling of fullness after eating and, in turn, tends to reduce the frequency of eating
The treatment also assists your body in expelling excess fat that has settled into your bloodstream, which automatically leads to a higher calorie burn
While this reduction would present a volume headwind for packaged food and beverage companies and restaurants, companies may also have opportunities to evolve product offerings to adapt to the changing diets of GLP-1 patients, both while they are on the drug and following treatment
He recommended that I increase my protein intake and start full-body strength training to grow muscle, support my bone health, and improve my overall longevity